Skip to content
Clinical Trials – home
SloveniaBack to Slovenia

Clinical trials in Ljubljana

92 clinical trials in Ljubljana, Slovenia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SloveniaOur site in SloveniaKlinicnaPreskusanja.si(opens in a new tab)
Ljubljana at a glance
92
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

92 trials in Ljubljana

Open in trial search
Countries:SloveniaSlovenia
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Empasiprubart
  • Sponsor:Argenx
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Amgen Inc.
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Bleomycin Sulfate Ph. Eur.
  • Sponsor:Institute Of Oncology Ljubljana
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Remibrutinib
  • Sponsor:Novartis Pharma AG
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Empasiprubart
  • Sponsor:Argenx
Countries:SloveniaSlovenia
  • Participants:0–17 years · 18–64 years
  • Substances:Sodium Chloride
  • Sponsor:Sab Biotherapeutics Inc.
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Azd8205
  • Sponsor:AstraZeneca AB
Countries:SloveniaSlovenia
  • Participants:0–17 years
  • Substances:ADENO-ASSOCIATED VIRAL VECTOR SEROTYPE 9 CONTAINING THE HUMAN CTNNB1 GENE
  • Sponsor:Fundacija CTNNB1 Ustanova Za Raziskave Na Podrocju Genske Terapije
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:IMEROPRUBART
  • Sponsor:Immunovant Sciences GmbH
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Institute Of Oncology Ljubljana

Other cities in Slovenia

The busiest research cities in the country

All 17 cities in Slovenia

Clinical research in Ljubljana

What the registry says about research in the country

01 Autoimmune Conditions

Innovative research focusing on Sjögren's Syndrome and inflammatory bowel conditions, including studies evaluating novel therapeutic approaches for Crohn's Disease and Ulcerative Colitis.

  • Dazodalibep safety trials
  • Combination therapy assessments
  • Advanced treatment protocols

Multiple studies investigating long-term effectiveness and patient outcomes in chronic inflammatory conditions.

02 Cardiovascular Research

Comprehensive studies addressing cardiovascular disease and related conditions, including research on lipoprotein management and cardiac inflammation treatments.

  • Lipid-lowering therapies
  • Acute myocarditis treatment
  • Pulmonary embolism management

Focus on preventive measures and innovative therapeutic approaches for various cardiac conditions.

03 Oncology Studies

Advanced research in cancer treatment, including studies on breast cancer, melanoma, and various blood cancers.

  • Endocrine therapy optimization
  • Immunotherapy combinations
  • Leukemia treatment protocols

Emphasis on personalized treatment approaches and improved patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).